Study identification

EU PAS number

EUPAS29910

Study ID

47198

Official title and acronym

Venous Thromboembolism Treatment (VOLT)

DARWIN EU® study

No

Study countries

Finland
Norway
Sweden

Study description

A retrospective, observational study of patients prescribed an OAC following a VTE event after the 1 January 2013 or the marketing date of NOACs in each country, whichever occurs last, using nationwide registries from multiple Nordic countries (Sweden, Norway, and Finland).

Study status

Ongoing
Research institutions and networks

Institutions

PPD Evidera
Sweden
United Kingdom
United States
First published:
22/09/2025
Institution Laboratory/Research/Testing facility Non-Pharmaceutical company ENCePP partner

Contact details

Jenkins Aaron

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Sources of funding
Pharmaceutical company and other private sector 

More details on funding

BMS/Pfizer
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable